Inventor · disambiguated record
Ning Shao
Also filed as: SHAO NING
16 granted patents·9 pending applications·33 citations·filing 2009–2024
90Inventor score
Files withBEIJING TIDE PHARMACEUTICAL CO LTD7MERCK SHARP & DOHME3BIOARDIS LLC2GRITSCIENCE BIOPHARMACEUTICALS CO LTD2MCCORMICK KEVIN D2
Top patents by PatentIndex Score
25 records- 0195US11919918B2P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2022·Granted Mar 5, 2024·6 cites·20 claims
- 0291US12180243B2Receptor inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2022·Granted Dec 31, 2024·2 cites·74 claims
- 0389US11414444B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 16, 2022·5 cites·15 claims
- 0486US11453690B2Receptor inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 27, 2022·3 cites·50 claims
- 0580US12509479B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2024·Granted Dec 30, 2025·0 cites·17 claims
- 0679US2025066398A1Receptor inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0778US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 0878US8592383B2Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulatorsHUANG XIANHAI·Filed 2012·Granted Nov 26, 2013·5 cites·48 claims
- 0976US10239863B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Mar 26, 2019·1 cites·19 claims
- 1066US8324213B2Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2009·Granted Dec 4, 2012·1 cites·11 claims
- 1165US8283360B2Bicyclic heterocyclic derivatives and methods of use thereofPALANI ANANDAN·Filed 2009·Granted Oct 9, 2012·1 cites·2 claims
- 1264US11279697B2Aromatic derivative, preparation method for same, and medical applications thereofBIOARDIS LLC·Filed 2018·Granted Mar 22, 2022·1 cites·22 claims
- 1363US8889683B2Substituted quinoxalines as inhibitors of fatty acid binding proteinCHENG CLIFFORD·Filed 2011·Granted Nov 18, 2014·2 cites·9 claims
- 1460US2025092017A12-piperidyl or 2-pyrazolyl substituted pyrimidine compound serving as egfr inhibitorSUZHOU PUHE BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1558US2016257668A1Factor XIa InhibitorsSHAO NING·Filed 2014·Application pending·0 cites
- 1655US8569312B2Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 29, 2013·0 cites·11 claims
- 1754US8476274B2Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2012·Granted Jul 2, 2013·0 cites·10 claims
- 1849US2025276972A1Compounds as casein kinase inhibitorsGRITSCIENCE BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1948US2023192699A1Compounds as casein kinase inhibitorsGRITSCIENCE BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2046US2016229839A1Factor XIa InhibitorsMERTZ ERIC·Filed 2014·Application pending·0 cites
- 2144US11976058B2Aromatic derivatives, preparation methods, and medical uses thereofBIOARDIS LLC·Filed 2020·Granted May 7, 2024·0 cites·48 claims
- 2243US11905274B2Receptor inhibitors, pharmaceutical compositions comprising the same and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 20, 2024·0 cites·44 claims
- 2334US2019240646A1Mesoporous manganese ferrite fenton-like catalyst, preparation method therefor, and application thereofNANJING UNIVERSITY OF TECHNOLOGY·Filed 2017·Application pending·0 cites
- 2432US2013079271A1Reversed biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2010·Application pending·0 cites
- 2530US2011207734A1Azine Derivatives and Methods of Use ThereofPALANI ANANDAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ning Shao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →